U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269886) titled 'BIOMARKERS FOR DRUG SELECTION IN DEPRESSION' on Nov. 21.
Brief Summary: The study aims to assess whether providing Clinical Decision Support Software (CDSS) information improves the pharmacological response in patients with depression. The CDSS integrates genomic, clinical, and blood biomarker data to assist psychiatrists in selecting the most appropriate treatment for each patient.
A total of 72 patients diagnosed with Major Depressive Disorder were recruited. Participants were male and female adults aged 18 to 65 years, all presenting with moderate to severe symptomatology as assessed by the HAM-D-17 scale.
Enrolled patients were...